Follow
Dima Sabbah
Title
Cited by
Cited by
Year
Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors
DA Sabbah, R Hajjo, K Sweidan
Current topics in medicinal chemistry, 2020
2982020
Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases
DA Sabbah, JL Vennerstrom, H Zhong
Journal of chemical information and modeling 50 (10), 1887-1898, 2010
792010
Shedding the light on post-vaccine myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients
R Hajjo, DA Sabbah, SK Bardaweel, A Tropsha
Vaccines 9 (10), 1186, 2021
752021
Dual inhibitors of PI3K/mTOR or mTOR-selective inhibitors: which way shall we go?
D a Sabbah, M G Brattain, H Zhong
Current medicinal chemistry 18 (36), 5528-5544, 2011
642011
Sitagliptin: a potential drug for the treatment of COVID-19?
S Bardaweel, R Hajjo, D Sabbah
Acta Pharmaceutica, 2020
472020
An updated review on SARS-CoV-2 main Proteinase (MPro): protein structure and small-molecule inhibitors
DA Sabbah, R Hajjo, SK Bardaweel, HA Zhong
Current Topics in Medicinal Chemistry 21 (6), 442-460, 2021
402021
Binding selectivity studies of phosphoinositide 3-kinases using free energy calculations
DA Sabbah, JL Vennerstrom, HA Zhong
Journal of chemical information and modeling 52 (12), 3213-3224, 2012
402012
Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα)
DA Sabbah, M Saada, RA Khalaf, S Bardaweel, K Sweidan, T Al-Qirim, ...
Bioorganic & Medicinal Chemistry Letters 25 (16), 3120-3124, 2015
392015
N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)
DA Sabbah, NA Simms, W Wang, Y Dong, EL Ezell, MG Brattain, ...
Bioorganic & medicinal chemistry 20 (24), 7175-7183, 2012
392012
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases
DA Sabbah, NA Simms, MG Brattain, JL Vennerstrom, H Zhong
Bioorganic & medicinal chemistry letters 22 (2), 876-880, 2012
382012
Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors
K Sweidan, DA Sabbah, S Bardaweel, KA Dush, GA Sheikha, ...
Bioorganic & medicinal chemistry letters 26 (11), 2685-2690, 2016
372016
Advances in the development of class i phosphoinositide 3-kinase (PI3K) inhibitors
DA Sabbah, J Hu, HA Zhong
Curr. Top. Med. Chem 16 (13), 1413-1426, 2016
362016
Monoamine oxidase (MAO) as a potential target for anticancer drug design and development
R Aljanabi, L Alsous, DA Sabbah, HI Gul, M Gul, SK Bardaweel
Molecules 26 (19), 6019, 2021
292021
Phosphatidylinositol 3-kinase (PI3K) inhibitors: A recent update on inhibitor design and clinical trials (2016–2020)
DA Sabbah, R Hajjo, SK Bardaweel, HA Zhong
Expert Opinion on Therapeutic Patents 31 (10), 877-892, 2021
272021
Synthesis and preliminary biological evaluation of new heterocyclic carboxamide models
K Sweidan, J Engelmann, W Abu Rayyan, D Sabbah, M Abu Zarga, ...
Letters in Drug Design & Discovery 12 (5), 417-429, 2015
272015
Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents
DA Sabbah, F Al-Tarawneh, WH Talib, K Sweidan, SK Bardaweel, ...
Medicinal Chemistry 14 (7), 695-708, 2018
252018
Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones
S Arabiyat, V Kasabri, Y Al‐Hiari, YK Bustanji, R Albashiti, IM Almasri, ...
Chemical Biology & Drug Design 90 (6), 1282-1294, 2017
252017
Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies
DA Sabbah, HA Zhong
Journal of Molecular Graphics and Modelling 68, 206-215, 2016
222016
Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers
R Hajjo, DA Sabbah, AQ Al Bawab
Diagnostics 12 (7), 1742, 2022
212022
Structure-based design: Synthesis, X-ray crystallography, and biological evaluation of N-substituted-4-hydroxy-2-quinolone-3-carboxamides as potential cytotoxic agents
DA Sabbah, B Hishmah, K Sweidan, S Bardaweel, M AlDamen, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018
192018
The system can't perform the operation now. Try again later.
Articles 1–20